Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- OXFORD BIOMEDICAL RESEARCH, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NQTNG8N1R3Q8
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant):
This project will explore the application of a dual-secondary column
comprehensive two-dimensional gas chromatograph (GC x 2GC) to characterize and
quantitate exposure to toxic chemicals. GC x 2GC provides high resolution,
high sensitivity, and short analysis times for a fraction of the cost of gas
chromatography/mass spectrometry techniques. In Phase I, (a) a working GC x
2GC prototype will be constructed and characterized, (b) a retention database
will be developed to allow peaks to be identified under a wide range of
chromatographic conditions, and (c) volatile organic compound profiles of
human breath samples from smokers and nonsmokers will be analyzed using the
GC x 2GC system. The high-speed and high-resolution of the GC x 2GC
instrument allows breath samples to be comprehensively characterized in a few
minutes.
In Phase II studies, the investigators will (a) employ established animal
models to determine if GC x 2GC analysis of breath can detect organ-specific
toxicity; (b) use neural/fuzzy algorithms to search for compounds or patterns
of compounds indicative of exposure; and (c) characterize the specificity and
sensitivity of specific compounds thus identified as markers of toxicity.
PROPOSED COMMERCIAL APPLICATION:
Although it has been demonstrated that breath analysis can be used to characterize exposure and reaction to toxicants, conventional GC/MS methodology is very expensive and time-consuming. The relatively low cost, high-speed and high-resolution of the novel GC x 2GC instrument under evaluation allows breath samples to be comprehensively characterized in a few minutes. Once fully developed, there is expected to be a significant market for this instrument and for assay services that employ it. This market will include real time ananlysis of air in sites exposure, and parallel monitoring and tracking of exposed individuals.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
44 SBIR/STTR records share this UEI (1985–2021). Reported award amounts total $7,846,299. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Agriculture, Department of Defense
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards